XML 39 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2019
Option Indexed to Issuer's Equity [Line Items]  
Schedule of common stock issuable
  December 31, 
   2019   2018 
   Amount   Shares   Amount   Shares 
                 
Shares issuable pursuant to consulting agreements  $93,377    493,142   $26,137    114,080 
Shares issuable to employees   7,161    75,000         
Shares issuable pursuant to stock subscriptions received   59,000    479,762         
   $159,538    1,047,904   $26,137    114,080 
Schedule of stock warrants
   2019   2018 
       Weighted       Weighted 
       Average       Average 
       Exercise       Exercise 
   Number   Price   Number   Price 
Outstanding at beginning of the period   46,161,463   $0.18    20,526,387   $0.23 
Granted during the period   5,864,843   $0.22    27,635,819   $0.10 
Exercised during the period   (4,970,013)  $0.00    (2,000,744)  $(0.00)
Terminated during the period      $       $ 
Outstanding at end of the period   47,056,293   $0.21    46,161,462   $0.18 
                     
Exercisable at end of the period   47,056,293   $0.21    46,161,462   $0.18 
                     
Weighted average remaining life   3.0 years    3.8 years 
Schedule of stock warrants outstanding
   2019   2018 
Outstanding at beginning of the period   1,738,750    1,498,750 
Granted during the period   135,313    440,000 
Terminated during the period       (200,000)
Outstanding at end of the period   1,874,063    1,738,750 
           
Shares vested at period-end   1,535,313    1,198,750 
Weighted average grant date fair value of shares granted during the period  $0.26   $0.30 
Aggregate grant date fair value of shares granted during the period  $12,805   $107,197 
Shares available for grant pursuant to EIP at period-end   10,360,368    10,075,934 
Schedule of stock options outstanding
   2019   2018 
       Weighted       Weighted 
       Average       Average 
       Exercise       Exercise 
   Number   Price   Number   Price 
Outstanding at beginning of the period   3,707,996   $0.18    2,349,996   $0.12 
Granted during the period   1,078,750   $0.26    1,383,000   $0.29 
Exercised during the period   (154,166)  $0.20       $ 
Forfeited during the period   (1,363,330)  $0.18    (25,000)  $0.15 
Outstanding at end of the period   3,269,250   $0.21    3,707,996   $0.18 
                     
Options exercisable at period-end   1,633,000         1,375,583      
Weighted average remaining life (in years)   7.7         8.1      
Weighted average grant date fair value of options granted during the period  $0.20        $0.22      
Options available for grant at period-end   10,360,368         10,075,684      
Warrant [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Schedule of stock options outstanding
Warrants Outstanding   Warrants Exercisable 
        Weighted-             
        Average   Weighted-       Weighted- 
        Remaining   Average       Average 
Exercise   Number   Contractual   Exercise   Number   Exercise 
Prices   Outstanding   Life (years)   Price   Exercisable   Price 
$0.0001 to 0.09    15,287,011    4.9   $0.07    15,287,011   $0.07 
$0.10 to 0.24    17,735,322    3.4   $0.18    17,735,322   $0.18 
$0.25 to 0.49    10,093,960    4.4   $0.29    10,093,960   $0.29 
$0.50 to 1.00    3,940,000    2.2   $0.28    3,940,000   $0.28 
$0.05 to 1.00    47,056,293    4.0   $0.18    47,056,293   $0.18 
Employee Stock Option [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Schedule of stock warrants outstanding
Options Outstanding   Options Exercisable 
        Weighted-             
        Average   Weighted-       Weighted- 
        Remaining   Average       Average 
Exercise   Number   Contractual   Exercise   Number   Exercise 
Prices   Outstanding   Life (years)   Price   Exercisable   Price 
$— to 0.10    1,283,000    6.0   $0.08    1,258,000    0.08 
$0.11 to 0.31    1,986,250    8.9   $0.29    375,000    0.31 
$0.08 to 0.31    3,269,250    7.7   $0.21    1,633,000   $0.13 
Schedule of non-vested shares issued
    2019   2018 
        Weighted       Weighted 
        Average       Average 
        Grant Date       Grant Date 
    Shares   Fair Value   Shares   Fair Value 
Nonvested at beginning of period    2,332,413   $0.13    1,774,996   $0.03 
Granted    1,078,750   $0.20    1,383,000   $0.22 
Vested    (414,583)  $0.19    (803,583)  $0.05 
Forfeited    (1,360,330)  $0.07    (22,000)  $0.12 
Nonvested at end of period    1,636,250   $0.22    2,332,413   $0.13 
Employee Equity Incentive Plan [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Schedule of shares issued and outstanding under the EIP outstanding
    2019   2018 
        Weighted       Weighted 
        Average       Average 
        Grant Date       Grant Date 
    Shares   Fair Value   Shares   Fair Value 
Nonvested at beginning of period    540,000   $0.16    628,750   $0.05 
Granted       $    440,000   $0.24 
Vested    (207,500)  $0.14    (328,750)  $0.13 
Forfeited       $    (200,000)  $0.04 
Nonvested at end of period    332,500   $0.17    540,000   $0.16